th anniversary Abstract A series of 22 quinazolines, pyrido [2,3-d]pyrimidines and their hydroselenite salts were synthesized with the aim of evaluating in vitro their cytotoxicity against PC-3 cell line and their antioxidant properties related to DPPH (1,1-diphenyl-2-picrylhydrazylradical) activity, showing some of them better profile than the respective controls. Three of these derivatives (5d, 6d and 7f) were selected in order to gain preliminary insights to establish the mechanism of action. Caspase-3 activity and cell cycle regulation studies revealed that compound 6d provoked an increase in caspase-3 level accompanied by cell cycle perturbation in a time-dependent manner.
Introduction
Although the development of novel targeted antitumor drugs have obtained important progress in recent years, cancer remains the major leading cause of death in the world due to drug resistance or undesirable toxic effects. Quinazoline derivatives have been utilized extensively in medicinal chemistry due to its privileged structure that shows various pharmacological activities, such as antifungal, 1 antibacterial, 2 anti-inflammatory, 3 anticonvulsant 4 , antihypertensive 5 and anticancer activities [6] [7] [8] among others. This scaffold has been identified as new class of cancer chemotherapeutic agents acting as potent inhibitors for epidermal growth factor receptor (EGFR), 9 or dihydrofolate reductase. 10 Furthermore, its ability to induce apoptosis, 11, 12 or modulate caspases 13 as well as its capacity to bind the DNA have also been reported.
Moreover, the anticancer activity of photoactivable drugs containing the quinazoline moiety has been evaluated. 15 On the other hand, pyrido [2,3-d] pyrimidine derivatives are of great interest due to their anticancer or antiproliferative activities. [16] [17] [18] They exhibited very diverse biological profiles. Some members of this family inhibited tyrosine kinases 19 whereas others inhibited nonreceptor tyrosine kinases such us PI3K and mTOR. 20 Thus, pyridopyrimidine derivatives produced dihydrofolate reductase inhibition 21 as well as cell cycle modulation. 22 Selenium (Se) is an essential trace element that has been identified as an anticarcinogenic agent, with supporting evidence from epidemiological studies, clinical intervention trials, preclinical intervention studies (animal cancer models) and cell culture studies. Natural organic and inorganic sources of Se as well as synthetic organoselenium compounds have been shown to be effective and safe in the treatment and prevention of cancer. [23] [24] [25] [26] The observations outlined above, along with our experience in the synthesis and antitumoral studies related to quinazoline and pyrido [2,3-d] pyrimidines, [27] [28] [29] [30] [31] so as a continuation with our efforts in the search of new selenium derivatives with antitumoral properties [32] [33] [34] [35] [36] [37] [38] enthused us to develop new 2,4-disubstituted quinazoline and pyrido [2,3-d] pyrimidine derivatives. The linkages investigated were (-NH-), which was inserted in positions 2 and/or 4, and sulfur which was introduced in the 2-position. Bonded to these linkages, aliphatic chains of variable length with aryl rings at the end of the chain were placed. In addition, in the aryl rings different chemical functions that are present in a number of antineoplastic agents [39] [40] [41] such as methylthio, methylseleno or selenocyanate were introduced in order to verify their possible influence on the biological activity. The choice of different or identical substituents in 2 and 4 positions was done with the aim of corroborating the importance of molecular symmetry in the biological activity. Many literature reports include molecules that possess symmetry as cytotoxic agents. 42 Finally, to improve the low water solubility and bioavailability, that has limited the development of some of these compounds, some derivatives were formulated as hydroselenite salts. All the derivatives were screened by cell viability assays against a human prostate cancer cell line (PC-3) and as antioxidants using the DPPH test. In order to gain preliminary insights related to the mechanism of action, some of the most promising compounds were also evaluated as caspase modulators and cell cycle regulators.
pyrido [2,3- 
The susbstituted 4-alkylamino-2-methylthio derivatives of quinazoline and pyrido [2,3-d] pyrimidine have been synthesized in two steps (Scheme 1) starting from compounds 1 and 2, respectively. Upon refluxing with freshly distilled phosphoryl chloride (POCl 3 ) in presence of dimethylformamide (DMF), compounds 1 and 2 yielded the corresponding key 4-chloro intermediates 3 and 4, which were used without purification. Reaction of 3 and 4 with the appropriate amine in a molar ratio 1:1.1 respectively, in ethanol by refluxing gave the desired compounds 5a-5d in yields ranging from 4 to 60 %. Compounds 5a-5d were converted in hydroselenite salts (6a-6d) by reaction with selenium dioxide in heating in a mixture ethanol:water (1:1) (Scheme 1). a: POCl 3 /DMF; b: phenylalkylamine, EtOH; c: SeO 2 , EtOH:H 2 O (1:1). Scheme 1. Synthetic routes for the preparation of compounds 5a-5d and 6a-6d.
On the other hand, the commercially available compounds A or B (Scheme 2) reacted with phosphoryl chloride in the presence of DMF in one step to give the corresponding dihalides which were further reacted with the appropriated amines in ethanol using triethylamine (TEA) as catalist to afford the target compounds (7a-7h) with good yields. The corresponding salts (8a-8f) were obtained by treating selenium dioxide with the organic free bases quinazoline and pyridopyrimidine, respectively. Salts (6a-6d and 8a-8f) were characterized by a broad singlet in 1 H NMR spectrum (Scheme 2).
extensive literature review, this cell line was selected considering that many clinical trials suggest a role of some selenium compounds in the reduction of prostate cancer. [44] [45] [46] Results are tabulated as IC 50 values. IC 50 was defined as the concentration of tested compound that cause 50% inhibition of cell growth, as compared to the untreated control. IC 50 values were calculated by log-linear interpolation of data points. All experiments were independently performed at least three times and values calculated after 72 hours exposure (drug concentrations of 2, 5, 7 and 10 µM). These concentrations have been chosen with an exigent criteria in order to select very potent compounds (with IC 50 < 10 µM). To place the data in perspective, topotecan and methylseleninic acid were selected as positive controls. The results presented in Table 1 show that twelve compounds 5d, 6a, 6c, 6d, 7b, 7e, 7f, 7h, 8b, 8c, 8e and 8f with IC 50 < 8 µM are more potent than methylseleninic acid (IC 50 = 8.4 µM) exhibiting seven of them (6a, 6c, 7e, 7f, 7h, 8e and 8f) higher cytotoxicity than topotecan (IC 50 = 4.0 µM). A detailed SAR analysis is not feasible taking into account the relatively small number of derivatives tested, but some observations and comparisons can be made. This primary screening reveals that the pyridopyrimidine nucleus is better than the corresponding quinazoline, mainly when the substituents in 2 and 4 positions are different. For example, if we compare derivatives 5c (IC 50 > 10 µM) with 5d (IC 50 = 5.8 µM) or compound 7a (IC 50 >10 µM) with 7b (IC 50 = 8.0 µM). In contrast, for symmetrical derivatives 7c and 7d, or 7e and 7f the activities are similar. Moreover, it has been confirmed that molecular symmetry improved the cytotoxic activity in comparison with non-symmetrical derivatives. For example, only four compounds (5d, 6a, 6c and 6d) of the non-symmetrical molecules (5a-5d and 6a-6d) were active. However, from the rest of the tested derivatives (14) , that presented molecular symmetry, ten of them showed activity. The length of the alkylamino side chains is not crucial for the cytotoxicity when the linkages inserted in positions 2 and 4 are identical. Compounds 7a (m = 1) versus 7c (m = 4) indicated that the cytotoxicity may not be affected by the length of alkyl substituents. Another aim of this study was to test the importance of the presence of hydroselenite salt in the formulation. Previously, some studies of Arsenyan et al. [47] [48] [49] have reported the cytotoxic activity against hepatoma, fibrosarcoma, melanoma, neuroblastoma of some heterocycles formulated as hydroselenites. Taking into account the above aforementioned we concluded that the effect of hydroselenite salts formulation depends of the central scaffold. So, hydroselenite salts enhanced the cytotoxicity of quinazoline heterocycle framework compounds: 5a versus 6a, 5c versus 6c, 7a versus 8a, 7c versus 8c but they do not modified it or have a weak effect in pyridopyrimidine derivatives: 5b versus 6b, 5d versus 6d, 7b versus 8b.
The presence of substituents SCH 3 or SeCH 3 located at para position of the aryl moiety improved the cytotoxicity independently of the formulation as salt or of the central scaffold. This point is corroborated by the fact that if we compared the activities of 7e, 7f, 7h, 8e, and 8f, they are similar (IC 50 from 1.5 to 3.2 µM). To our surprise, 7g with SeCN group at para position did not show as marked cytotoxic activity on this cell line (IC 50 = 9.4 µM). This fact may be due to the replacement of the flexible aliphatic side chains (n and m = 1) by a rigid chain (n and m = 0). b) Antioxidant activity Since antioxidants are gaining attention as a potential means of treating a large number of lifestyle diseases like cancer, it is of immense significance to establish some new antioxidants via a convenient synthetic methodology. In addition, selenium derivatives are being studied due to their antioxidant properties. 50, 51 The DPPH radical has been widely used to test the ability of compounds to behave as free radical scavengers or hydrogen donors. Briefly, the assay measures the decrease in absorbance of the DPPH radicals at a characteristic wavelength after 60 min incubation of the DPPH radical with different concentrations (from 62.5 µM to 312.5 µM) of the antioxidant compound according to the method of Koparir et al. 52 The absorbance of the reaction mixture was recorded at 517 nm using a UV visible spectrophotometer (Jasco V-630). Ascorbic acid was used as standard. Results are expressed as the percentage of the DPPH free radical scavenging at five concentrations, as shown in Table 2 . Each value is expressed as the average of three experiments per concentration ± SD. Although all the compounds were tested, Table 2 only shows the data obtained for the derivatives that exhibited some activity. 6d showed the best DPPH radical scavenging activity in comparison with ascorbic acid used as reference, followed by compounds 7f, 5c, 6c, 7g, 5a and 8e. In general, analogues with quinazoline moiety presented better DPPH radical scavenging activity at the concentrations tested than compounds with pyridopyrimidine moiety with the exception of 6d and 7f. c) Mechanism Studies Since some compounds had strong inhibitory effects on the growth of the cancer cell line tested, and/or antioxidant activity, we decided to study the effect of three compounds (5d, 6d and 7f) in greater detail in order to know their mode of action. 6d, formulated as hydroselenite salt, because it is active against PC-3 and exhibited a marked antioxidant activity being better than ascorbic acid used as positive control; its analogue 5d with the same chemical structure in order to explore the importance of the presence of hydroselenite group in the mechanism of action and 7f, which was the most active as cytotoxic agent (IC 50 = 1.5 µM) and one of the most potent derivative as DPPH radical scavenging. First, we investigated the effects of these three compounds on caspase activity. We focused on caspase-3, which is activated by a great number of apoptotic signals. This enzyme is the main executor of apoptosis playing a central role in its biological processing. It has been reported that activation of caspase-3 is an essential event for the induction of oligonucleosomal DNA fragmentation. 53 We analysed the effect of treatment with 5d, 6d and 7f on caspase-3 activation in PC-3 at a concentration of 15 µM after 24 and 48 h of treatment. As shown in Figure 1 , the activity of caspase-3 in cells exposed to compound 6d increased slightly comparing to control after 24 h, although this effect disappeared after 48 h. However, the analogue without hydroselenite salt (5d) and compound 7f did not modify the caspase-3 level at the times tested. Then, these compounds were selected for further evaluation on their effects of PC-3 cell cycle distribution by flow cytometric analysis using propidium iodide at 24 and 48 h. It is known that cell cycle dysregulation is a hallmark of anticancer drug-induced cell death and many anticancer drugs interact with cells leading to cell growth arrest. 54 To determine whether the anticancer effects of the compounds were caused by cell cycle modulation, the effects of compounds 5d, 6d and 7f on cell cycle progression were examined in PC-3 cell line at a concentration of 15 µM. After 24 h and 48 h of treatment, compound 5d did not induce any specific phase arrest of the cell cycle related to control. In contrast, 6d at 24 h provoked an increase in phases subG 0 /G 1 and G 2 /M with a significant reduction of G 0 /G 1 . On the other hand, 7f induced a slightly decrease in the G 0 /G 1 population with a weak increase in other phases (S and G 2 /M). In all the cases these effects disappear at 48 h. Cell accumulation in G 2 /M phase, accompanied by a diminution of cell proportion in G 0 /G 1 phase accompanied by a significant increase in subGo/G 1 phase (which is representative of cell with fragmented DNA) could suggest a mitotic arrest prior to metaphase. Figure 2 summarizes the results of cell cycle distribution. Figure 2 . Effects of 5d, 6d and 7f on cell cycle distribution in PC-3 cells.
d) Theoretical evaluation of ADME properties To better understand the properties of the compounds, the theoretical ADME properties such as molecular weight, log P, TPSA (a predictive indicator of membrane penetration), volume and number of hydrogen donors and acceptors were calculated (Table 3 ) using the Molinspiration property calculation program. 55 From the obtained results, it is important to point out that the three selected compounds (5d, 6d and 7f) possess acceptable log P values, which mean that these derivatives could be able to cross membranes. Furthermore, values obtained from TPSA are also found to be positive. It can also be observed no violations of Lipinski´s rule (Table 3) . It is remarkable that this freely accessible program do not allow to include the hydroselenite salt formulation in the structure so the values obtained for compound 6d were determined by protonation of the amine group. 
Conclusions
The current study reports the synthesis of twenty-two quinazolines, pyrido [2,3-d] pyrimidines and their hydroselenite salts and the in vitro growth inhibitory activity against tumoral PC-3 cell line as well as their antioxidant activity considered as the interaction with the free radical DPPH. It was observed from the results of biological assays that twelve compounds (5d, 6a, 6c, 6d, 7b,  7e, 7f, 7h, 8b, 8c, 8e and 8f) showed potent growth inhibitory activity (IC 50 < 8.0 µM) and were more potent than standard drug methylseleninic acid (IC 50 = 8.4 µM). In addition, seven of them (6a, 6c, 7e, 7f, 7h, 8e and 8f) were more active than topotecan with IC 50 below than 4.0 µM. On the ground of the biological results, some structural features were inferred to be beneficial to the antitumor activity of such compounds. Cytotoxic data confirmed that molecular symmetry is a valid approach to obtain potent antitumor agents. In general, the hydroselenite salt formulation had a beneficial effect on the cytotoxic activity for 2 and 2 and 4-phenylalkylamino derivatives when the aryl ring was not functionalizated. Meanwhile, the modification of the length in the alkyl chain substituent was not accompanied by alteration of antitumor activity. The effect of the replacement of quinazoline by pyridopyrimidine scaffold was dependent of the nature of the substituents. Two compounds 6d and 7f exhibited strong cytotoxic and antioxidant activities in comparison to the positive controls and they were selected for further studies related to caspase-3 activity and cell cycle regulation. Compound 6d provoked caspase-3 activation and cell cycle arrest in a time-dependent manner being these effects less marked for 7f. In addition, the described compounds seem to present desirable ADME properties that could be an important information about the promising potential of these derivatives. These compounds may become a promising class of cytotoxic and antioxidant agents and the results provide an insight for future direction in the development of new molecules.
Experimental Section Chemistry
General. Melting points were determined with a Mettler FP82+FP80 apparatus (Greifense, Switzerland) and have not been corrected. 
General procedure for compounds 7a-7h
To 
General procedure for compounds 8a-8f
The corresponding derivatives 7a-7f (1 mmol) were dissolved in ethanol:water (1:1, 50 mL) and selenium dioxide (1.5 mmol) was added. The resulting mixture was heated and stirred during 3 h and the solvent was removed under reduced pressure. Finally, the residue was washed with (4 × 25 mL), dried and recrystallized from ethanol. N,N'-Dibenzylaminoquinazolin-2,4-diamonium hydroselenite (8a). Antioxidant activity. The antioxidant activity of the compounds was determined by the DPPH method. The free radical-scavenging activity of the title compounds was determined by spectrophotometric measurement of the change in the absorbance of DPPH at 517 nm. Stock solutions (500 mM) of the tested samples and DPPH were prepared in DMSO. DPPH solution (400 mM) was added to the sample solution at different concentrations (500, 1000, 1500, 2000 and 2500 mL) and appropriately diluted with DMSO to a total volume of 4.0 mL. A control was produced by diluting 400 µL from DPPH stock solution was also diluted to 4.0 mL using DMSO solvent. For the control, only solvent was added. Ascorbic acid was used as a standard (using the reference antioxidant) for this test. For the standard, the sample was replaced with the same amount of ascorbic acid. The DPPH radical scavenging method was chosen to assess the antioxidant potential of the target compounds in comparison with the commercially available antioxidant ascorbic acid at the same concentrations. The reaction mixtures were thoroughly mixed by shaking the test tubes vigorously and incubated in a water bath at 25 ºC for 60 min in darkness. Absorbance at 517 nm was measured and the solvent was corrected throughout. The scavenging effect was calculated using the following equation: A 0 -A S Scavenging activity (%): ----------× 100 A 0 where A S is the absorbance of the DPPH in the presence of the tested compounds and standard and A 0 is the absorbance of the DPPH in the absence of the tested compound and standard (control). Caspase-3 activity. Detection was carried out by means of flow cytometry (Coulter Epics XL), using the Active-Caspase-3 FITC Mab apoptosis kit from Pharmingen, which evaluates the number of cells (%) that are contained in the dimerized and caspase-3 activated form. Therefore, measurements were taken at 24 and 48 h and the values obtained were compared with the control cells. Cell cycle analysis. Cells were plated at a density of 5×10 5 cells/well in six-well plates and they were incubated ovenight at 37 ºC under 5% CO 2 . Then, cells were treated with 15 µM concentration of the tested compounds for 24 and 48 h. After the incubation period with the compounds, the cells were collected, centrifuged and fixed with ice-cold ethanol (70%). Cells were stained with 0.5 g/L propidium iodide and analyzed using a Coulter Epics XL flow cytometer.
